Events Calendar

Dissertation Defense: “Environmental Impacts on Clinical Outcomes and the Epigenome in Patients with Fibrotic Interstitial Lung Disease”

This is a past event.

Gillian Goobie, MD, FRCPC - Final Dissertation Defense - HUGEN PhD Candidate

Department of Human Genetics Doctoral Candidate, Gillian Goobie, MD, FRCPC, defends her dissertation on “Environmental Impacts on Clinical Outcomes and the Epigenome in Patients with Fibrotic Interstitial Lung Disease” 

ADVISOR: YINGZE ZHANG, PHD

Committee Members:

  • Ryan L. Minster, PhD, MSIS
  • John R. Shaffer, PhD
  • S. Mehdi Nouraie, MD, PhD
  • Daniel J. Kass, MD

 

ABSTRACT:

Fibrotic interstitial lung diseases (fILDs) are a group of conditions characterized by lung scarring, functional limitation, and a high morbidity and mortality. Air pollution and socioeconomic disadvantage have been linked with adverse outcomes in idiopathic pulmonary fibrosis (IPF), the most common form of fILD, but these impacts have not been evaluated in large, geographically-diverse cohorts of patients with fILD. This dissertation sought to evaluate the impact of particulate matter with a diameter of ³2.5um (PM2.5) and neighborhood-level disadvantage on clinical outcomes, genomic, and epigenomic mechanisms of disease in a diverse cohort of patients with fILD.

Aim 1 demonstrated that patients with fILD who live in neighborhoods with greater disadvantage in the U.S., but not Canadian cohort, experience increased mortality and lower odds of receiving lung transplant. This work highlights how health disparities may be exacerbated by healthcare system structure, and raises questions of how environmental factors in disadvantaged neighborhoods contribute to these adverse outcomes. Aim 2 demonstrated that increased exposures to PM2.5 and its anthropogenic constituents (particularly sulfate, nitrate, and ammonium) are associated with increased mortality and worse lung function in fILDs. Aim 3 demonstrated that PM2.5 and its constituents can influence DNA methylation (DNAm) patterns and telomere length in patients with fILD, and that these molecular changes may mediate PM2.5-mortality associations. We found that increased PM2.5, sulfate, and ammonium exposures were associated with higher global DNAm using an ELISA-based assay. Then, epigenome-wide association studies identified multiple CpGs associated with high exposures to PM2.5. Most significant CpGs were found in analyses of sulfate, ammonium, and sea salt PM2.5 constituents, highlighting the potentially greater mechanistic relevance for these components of the PM2.5 mixture. Lastly, we found that higher exposure to PM2.5 was associated with shorter telomere length, which mediates up to 20% of the PM2.5-mortality association.

By highlighting environmental impacts on clinical outcomes and molecular mechanisms of disease, we have unveiled potential causal pathways for how such exposures contribute to the development and progression of fILDs. This research has direct impacts on public health by providing critical data to inform environmental health policies that protect vulnerable populations.

Dial-In Information

HYBRID EVENT - ALL WELCOME (Advance Registration for ZOOM Link Required)

https://pitt.co1.qualtrics.com/jfe/form/SV_0p1DI3rIsZKoxJI

Wednesday, October 19 at 1:00 p.m. to 3:00 p.m.

School of Public Health, 1155 Public Health 130 DeSoto Street, Pittsburgh, PA 15261

Dissertation Defense: “Environmental Impacts on Clinical Outcomes and the Epigenome in Patients with Fibrotic Interstitial Lung Disease”

Gillian Goobie, MD, FRCPC - Final Dissertation Defense - HUGEN PhD Candidate

Department of Human Genetics Doctoral Candidate, Gillian Goobie, MD, FRCPC, defends her dissertation on “Environmental Impacts on Clinical Outcomes and the Epigenome in Patients with Fibrotic Interstitial Lung Disease” 

ADVISOR: YINGZE ZHANG, PHD

Committee Members:

  • Ryan L. Minster, PhD, MSIS
  • John R. Shaffer, PhD
  • S. Mehdi Nouraie, MD, PhD
  • Daniel J. Kass, MD

 

ABSTRACT:

Fibrotic interstitial lung diseases (fILDs) are a group of conditions characterized by lung scarring, functional limitation, and a high morbidity and mortality. Air pollution and socioeconomic disadvantage have been linked with adverse outcomes in idiopathic pulmonary fibrosis (IPF), the most common form of fILD, but these impacts have not been evaluated in large, geographically-diverse cohorts of patients with fILD. This dissertation sought to evaluate the impact of particulate matter with a diameter of ³2.5um (PM2.5) and neighborhood-level disadvantage on clinical outcomes, genomic, and epigenomic mechanisms of disease in a diverse cohort of patients with fILD.

Aim 1 demonstrated that patients with fILD who live in neighborhoods with greater disadvantage in the U.S., but not Canadian cohort, experience increased mortality and lower odds of receiving lung transplant. This work highlights how health disparities may be exacerbated by healthcare system structure, and raises questions of how environmental factors in disadvantaged neighborhoods contribute to these adverse outcomes. Aim 2 demonstrated that increased exposures to PM2.5 and its anthropogenic constituents (particularly sulfate, nitrate, and ammonium) are associated with increased mortality and worse lung function in fILDs. Aim 3 demonstrated that PM2.5 and its constituents can influence DNA methylation (DNAm) patterns and telomere length in patients with fILD, and that these molecular changes may mediate PM2.5-mortality associations. We found that increased PM2.5, sulfate, and ammonium exposures were associated with higher global DNAm using an ELISA-based assay. Then, epigenome-wide association studies identified multiple CpGs associated with high exposures to PM2.5. Most significant CpGs were found in analyses of sulfate, ammonium, and sea salt PM2.5 constituents, highlighting the potentially greater mechanistic relevance for these components of the PM2.5 mixture. Lastly, we found that higher exposure to PM2.5 was associated with shorter telomere length, which mediates up to 20% of the PM2.5-mortality association.

By highlighting environmental impacts on clinical outcomes and molecular mechanisms of disease, we have unveiled potential causal pathways for how such exposures contribute to the development and progression of fILDs. This research has direct impacts on public health by providing critical data to inform environmental health policies that protect vulnerable populations.

Dial-In Information

HYBRID EVENT - ALL WELCOME (Advance Registration for ZOOM Link Required)

https://pitt.co1.qualtrics.com/jfe/form/SV_0p1DI3rIsZKoxJI

Wednesday, October 19 at 1:00 p.m. to 3:00 p.m.

School of Public Health, 1155 Public Health 130 DeSoto Street, Pittsburgh, PA 15261

Event Type

Defenses

Topic

Research

Hashtag

#PittPubHealth

Powered by the Localist Community Events Calendar ©